Search results
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 2 days agoThe boy had received Pfizer’s fordadistrogene movaparvovec, an investigational recombinant...
FDA issues recall for diabetes app after over 200 reported injuries
Popular Science via Yahoo News· 8 hours agoInitially approved by the FDA in February 2022, Tandem Medical Care’s t:connect iOS app was the...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 7 hours agoSchizophrenia Drugs Gain Speed The final piece of the Neurocrine Biosciences puzzle is its midstage...
Your Costa cappuccino could contain three times more caffeine than one from Cafe Nero - how can...
Cycling Weekly· 7 hours ago“Many of the team have their own Aeropress, and Rigoberto Urán even owns a coffee farm in Colombia...
Earnings call: Arcturus Therapeutics reports progress & Q1 losses
Investing.com· 18 hours agoCall that they are on track with the delivery of their COVID-19 vaccine, Kostaive, and are making...
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 hours agoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript May 8, 2024 Avadel...
Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the...
WTRF Wheeling· 6 days agoMitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an abstract in amyotrophic lateral sclerosis (ALS) at the Professional Society for Health Economics and Outcomes ...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 5 hours agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
Journal of the American Medical Association· 2 days agoThis stepped-wedge cluster trial evaluates the effectiveness of a rapid 5- to 7-day initiation of extended-release naltrexone compared with the standard 12- to 14-day procedure among individuals with opioid use disorder.
